Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

164.06
+3.892.43%
Volume:2.01M
Turnover:328.63M
Market Cap:254.46B
PE:24.56
High:164.53
Open:164.05
Low:162.14
Close:160.17
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.93
T/O Rate:0.13%
Dividend:3.17
Dividend Rate:1.93%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.06
PE(LYR):25.09

Loading ...

AstraZeneca Down Nearly 8%, on Pace for Largest Percent Decrease Since April 2025

Dow Jones
·
Aug 03

Movement Alert|AstraZeneca PLC Falls 7.22% in Regular Trading, Potential $400 Billion Merger With Bristol-Myers Squibb Sparks Integration Concerns

Market Focus
·
Aug 03

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Amid US-Iran Truce Hopes

MT Newswires Live
·
Aug 03

Potential merger between AstraZeneca and Bristol-Myers Squibb would create a cancer drug powerhouse, but analysts call it a 'strange' deal

Deep News
·
Aug 03

Sector Update: Healthcare

MT Newswires Live
·
Aug 03

Pre-Market: Nasdaq Futures Gain 0.32% as US and Japan Jointly Intervene in Currency Markets

Deep News
·
Aug 03

U.S. Stocks on the MOVE-Atkore, Integer, Airlines

Reuters
·
Aug 03

US Stocks-Wall St Futures Gain on Mideast Deal Hopes; Healthcare in Focus

Reuters
·
Aug 03

Citi views report of AstraZeneca, Bristol Myers talks as surprising

TIPRANKS
·
Aug 03

AstraZeneca Investors Might Question Pipeline After Reports of Merger Talks

Dow Jones
·
Aug 03

Stocks to Watch: Bristol Myers Squibb, Alibaba, Palantir

Dow Jones
·
Aug 03

Premarket Movers | Alibaba up 4%; Atkore jumps 25%; BMY up 6%; AZN down 6%; PLTR up 2%

Tiger Newspress
·
Aug 03

Movement Alert|AstraZeneca PLC Falls 6.12% in Pre-Market Trading, Reportedly in Merger Talks With Bristol-Myers Squibb in Potential Record Pharma Deal

Market Focus
·
Aug 03

AstraZeneca Could Want to Move Closer to U.S. Market

Dow Jones
·
Aug 03

Movement Alert|AstraZeneca PLC Declines 3.68% Overnight, Reportedly in Merger Talks with Bristol-Myers Squibb in Potential $400 Billion Mega-Deal

Market Focus
·
Aug 03

AstraZeneca Can Hit Revenue Target on Its Own

Dow Jones
·
Aug 03

J.P. Morgan Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Aug 03

AstraZeneca in discussions to combine with Bristol Myers for $400B, FT says

TIPRANKS
·
Aug 03

AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape

Stock News
·
Aug 03

Astrazeneca, Daiichi Sankyo's Breast Cancer Therapy Receives EU approval

MT Newswires Live
·
Jul 31